Regeneron

139 email addresses found for regeneron.com
{f}.{last}@regeneron.com
139 email addresses
1 source
http://nyas.org/ebriefings/cytokine-therapies October 10, 2017
1 source
http://biorxiv.org/content/early/2017/03/22/119461 September 9, 2017
3 sources
http://amcp.org/dynamicroster.aspx September 9, 2017
http://my.amcp.org/dynamicroster.aspx September 9, 2017
http://prod.amcp.org/dynamicroster.aspx September 9, 2017
13 sources
http://benzinga.com/pressreleases/17/11/n10831357/regeneron-provides-update-on-eylea-aflibercept-injection-and-nesvacuma March 3, 2018
http://boursica.com/message/7c7ex/sanofi-et-regeneron-annoncent-que-la-fda-a-accorde-la-designationethellip-sanofi-aventis.php January 1, 2018
http://euroinvestor.fr/actualites/2017/12/13/sanofi-and-regeneron-announce-positive-topline-pivotal-results-for-pd-1-antibody-cemiplimab-in-advanced-cutaneous-squamous-cell-carcinoma/13727192 January 1, 2018
http://euroinvestor.fr/actualites/2017/12/13/sanofi-et-regeneron-annoncent-les-premiers-resultats-positifs-dune-etude-pivot-consacree-a-lanticorps-anti-pd-1-cemiplimab-dans-le-traitement-du/13727191 January 1, 2018
http://i-professionnel.com/en/news-regeneron-and-sanofi-announce-cemiplimab-regn2810-has-received-fda-breakthrough-therapy-designation-for-advanced-cutaneous-squamous-cell-carcinoma-546429.html October 10, 2017
http://mediaroom.sanofi.com/sanofi-and-regeneron-announce-that-cemiplimab-regn2810-has-received-fda-breakthrough-therapy-designation-for-advanced-cutaneous-squamous-cell-carcinoma October 10, 2017
http://m.euroinvestor.com/news/2018/4/3/sanofi-ema-to-review-cemiplimab-as-a-potential-treatment-for-advanced-cutaneous-squamous-cell-carcinoma/13795054 April 4, 2018
http://news.genzyme.com/press-release/sanofi-and-regeneron-announce-cemiplimab-regn2810-has-received-fda-breakthrough-therap October 10, 2017
http://news.genzyme.com/press-release/sanofi-and-regeneron-present-positive-study-results-investigational-pd-1-antibody-regn September 9, 2017
http://news.sanofigenzyme.com/press-release/ema-review-cemiplimab-potential-treatment-advanced-cutaneous-squamous-cell-carcinoma April 4, 2018
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-announce-cemiplimab-regn2810-has-received-fda-breakthrough-therap October 10, 2017
http://news.sanofigenzyme.com/press-release/sanofi-and-regeneron-present-positive-study-results-investigational-pd-1-antibody-regn October 10, 2017
http://thenewsreports.com/sanofi-ema-to-review-cemiplimab-as-a-potential-treatment-for-advanced-cutaneous-squamous-cell-carcinoma/45639/staff April 4, 2018
9 sources
http://biorxiv.org/content/early/2017/01/06/098574 September 9, 2017
http://biorxiv.org/content/early/2017/01/09/098574 July 7, 2017
http://psb.stanford.edu/callfor/papers/cfp-drug October 10, 2017
http://science.sciencemag.org/content/354/6319/aaf6814 November 11, 2017
http://science.sciencemag.org/content/354/6319/aaf6814.long December 12, 2017
http://sergiostagnaro.wordpress.com/2016/03/03/tu-quoque-nejm-per-sconfiggere-la-cardiopatia-ischemica-bisogna-studiare-il-reale-rischio-congenito-di-cad September 9, 2017
http://sergiostagnaro.wordpress.com/tag/cad September 9, 2017
http://sergiostagnaro.wordpress.com/tag/cad-inherited-real-risk September 9, 2017
http://sergiostagnaro.wordpress.com/tag/teoria-microcircolatoria-dellarteriosclerosi October 10, 2017
2 sources
http://biorxiv.org/content/early/2017/01/06/098574 September 9, 2017
http://biorxiv.org/content/early/2017/01/09/098574 July 7, 2017
3 sources
http://nyas.org/ebriefings/bioscience-research-where-the-jobs-are November 11, 2017
http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2009.05074.x/full October 10, 2017
http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632.2009.05074.x/references November 11, 2016
1 source
http://journal.pda.org/content/70/3/293.abstract June 6, 2016
3 sources
http://biomedcareerfair.yale.edu/panelists April 4, 2016
http://biorxiv.org/content/early/2017/01/06/098574 September 9, 2017
http://biorxiv.org/content/early/2017/01/09/098574 July 7, 2017
2 sources
http://commonfund.nih.gov/komp2/meeting1/participants July 7, 2015
http://commonfund.nih.gov/KOMP2/meeting1/participants May 5, 2015
Show more results
129 more results for regeneron.com. Sign up or log in to access the full results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 800,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about regeneron.com

Industry: Science

Language of the website: English

Main technologies used:

Related companies

Med Immune
medimmune.com • 244 email addresses
North Carolina Museum Of Natural Sciences
naturalsciences.org • 254 email addresses
Springer
springer.com • 1457 email addresses
Learning Centers
lifetech.com • 300 email addresses
Merck
merck.com • 2899 email addresses
Denver Art Museum
denverartmuseum.org • 118 email addresses
Ucop
ucop.edu • 1225 email addresses
Omsi
omsi.edu • 94 email addresses
image/svg+xml

Hunter is the leading solution to find and verify professional email addresses. Search any domain name to find instantly the main email format used in an organization and all the email addresses publicly available on the web.

Discover Hunter

  1. Homepage
  2. Companies directory
  3. Science
  4. Regeneron